|
|
 |
International Clinical Trials in Hematology
Argentina
Australia
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Gosford; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Liverpool; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Melbourne; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Parkville; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Sydney; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Woolloongabba; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Gosford; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Liverpool; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Melbourne; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Parkville; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Perth; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Sydney; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia.
Woolloongabba; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Adelaide; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Gosford; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Melbourne; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Parkville; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Woolloongabba; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Adelaide; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Brisbane; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Melbourne; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
Adelaide; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
Brisbane; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
Melbourne; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Liverpool; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Melbourne; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Parkville; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Perth; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Adelaide; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Gosford; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Melbourne; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Parkville; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Adelaide; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Melbourne; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Parkville; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Sydney; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Adelaide; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Gosford; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Liverpool; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Melbourne; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Parkville; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
St. Leonards; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Sydney; Research Site:
- Anemia: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Woolloongabba; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Adelaide; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Frankston; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Gosford; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Malvern; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Melbourne; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Parkville; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Randwick; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Sydney; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Westmead; Research Site:
- Idiopathic Thrombocytopenic Purpura (ITP): A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Woolloongabba; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Adelaide; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Frankston; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Fremantle; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Melbourne; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Woolloongabba; Research Site:
Austria
Belgium
Brazil
- Anemia: (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
Sao Paulo; Research Site:
- Anemia: (BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
Belo Horizonte; Research Site:
- Anemia: (BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
Jaú; Research Site:
- Anemia: (BRAVE Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Metastatic Breast Cancer
Porto Alegre; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Curitiba; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Ribeirão Preto; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Sao Paulo; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Belo Horizonte; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Brasilia; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Campinas; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Campo Grande; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Cariacica; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Curitiba; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Fortaleza; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Jaboatão Dos Guararapes; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Joinville; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Juiz De Fora; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Londrina; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Natal; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Porto Alegre; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Ribeirão Preto; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Rio De Janeiro; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Salvador; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Sao Jose do Rio Preto; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Sao Luis; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Sao Paulo; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Sorocaba; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
Curitiba; Research Site:
- Anemia: A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
Sao Paulo; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Campinas; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Juiz De Fora; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Porto Alegre; Research Site:
- Anemia: A Study of Subcutaneous Mircera, Versus no ESA Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant.
Sao Paulo; Research Site:
- Anemia: LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Aracajú; Research Site:
- Anemia: LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Curitiba; Research Site:
- Anemia: LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Fortaleza; Research Site:
- Anemia: LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Sao Paulo; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Campinas; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Porto Alegre; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Santo Andre; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Sao Paulo; Research Site:
Bulgaria
Canada
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Kingston, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
London, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Mississauga, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Montreal, QC; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Saskatoon, SK; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
St John'S; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Toronto, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Weston, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Calgary, AB; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Edmonton, AB; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Halifax, NS; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Kamloops, BC; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Kitchener, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Mississauga, ON; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Vancouver, BC; Research Site:
- Anemia: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Winnipeg, MB; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
Greenfield Park, QC; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
Montreal, QC; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
Ottawa, ON; Research Site:
- Anemia: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
Toronto, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Calgary, AB; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Greenfield Park, QC; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Hamilton, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Kitchener, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Mississauga, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Ottawa, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Toronto, ON; Research Site:
- Anemia: A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients.
Trois-Rivieres, QC; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Kingston, ON; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
London, ON; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Montreal, QC; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
St John'S; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Toronto, ON; Research Site:
- Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients
Winnipeg, MB; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
Edmonton, AB; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
Montreal, QC; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Montreal, QC; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
North Vancouver, BC; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Ottawa, ON; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Sainte-Foy, QC; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Surrey, BC; Research Site:
- Anemia: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.
Vancouver, BC; Research Site:
- Anemia: A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
Halifax, NS; Research Site:
- Anemia: A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
Ottawa, ON; Research Site:
- Anemia: A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
St John'S; Research Site:
- Anemia: A Study of Mircera in Patients With Non-Hodgkin's Lymphoma and Anemia.
Toronto, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Edmonton, AB; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Greenfield Park, QC; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Kingston, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Kitchener, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
London, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Mississauga, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Montreal, QC; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Saskatoon, SK; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Scarborough, ON; Research Site:
- Anemia: A Study of Mircera in the Long Term Treatment of Patients With Renal Anemia.
Toronto, ON; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Calgary, AB; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Edmonton, AB; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Kamloops, BC; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Kitchener, ON; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
London, ON; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Montreal, QC; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
New Westminster, BC; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Saskatoon, SK; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Scarborough, ON; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
St John'S; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Toronto, ON; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Vancouver, BC; Research Site:
- Anemia: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Winnipeg, MB; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Calgary, AB; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Kingston, ON; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Mississauga, ON; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Montreal, QC; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
St John'S; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Toronto, ON; Research Site:
- Anemia: A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
Weston, ON; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Edmonton, AB; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
London, ON; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Montreal, QC; Research Site:
- Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis.
Toronto, ON; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Calgary, AB; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Edmonton, AB; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Greenfield Park, QC; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Halifax, NS; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Kingston, ON; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Mississauga, ON; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Moncton, NB; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Quebec City, QC; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Saskatoon, SK; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
St John'S; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Toronto, ON; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Windsor, ON; Research Site:
- Lymphoma, B-Cell: A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Winnipeg, MB; Research Site:
- Lymphomas: A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.
Greenfield Park, QC; Research Site:
- Lymphomas: A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.
Quebec City, QC; Research Site:
- Multiple Myelomas: A phase 2, randomized study of mapatumumab (TRM-1 [HGS1012], a fully human monoclonal antibody to TRAIL-R1) in combination with bortezomib (Velcade®) or bortezomib alone in patients with relapsed or refractory multiple myeloma.
Calgary, Alberta; Tom Baker Cancer Center
- Multiple Myelomas: A phase 2, randomized study of mapatumumab (TRM-1 [HGS1012], a fully human monoclonal antibody to TRAIL-R1) in combination with bortezomib (Velcade®) or bortezomib alone in patients with relapsed or refractory multiple myeloma.
Edmonton, Alberta; Cross Cancer Institute
Chile
China
Colombia
Czech Republic
Denmark
Ecuador
Estonia
Finland
France
| |
